The Advanced Medical Solutions Sector is engaged in leading-edge medicines CDMO (Contract Development and Manufacturing Organization) business, including long-chain oligonucleotides, small molecule drugs. We are also engaged in the manufacture and sale of RI diagnostic agents and research and development of regenerative medicine and cell therapies. Through these solutions and products, we aim to meet a diverse range of medical and healthcare needs, contributing to healthier and more fulfilling lives.
Pharmaceutical Chemicals
-
Active pharmaceutical ingredients
We engage in the manufacture and sale of APIs and intermediates outsourced from pharmaceutical companies, as well as pharmaceutical chemical products developed in-house, such as generic APIs, based on our advanced organic synthesis technologies and quality assurance capabilities. Nucleic acid medicines are next-generation pharmaceuticals, utilizing functions of oligonucleotides which act on genes and proteins that cause disease. We undertakes contract manufacturing for oligonucleotide APIs for pharmaceutical companies.
Nihon Medi-Physics Co., Ltd.
-
Manufacturing of PET radiopharmaceuticals
Nihon Medi-Physics is the leading company in the highly specialized field of nuclear medicine in both diagnosis and therapy.
It offers a comprehensive range of functions from research and development to production, marketing and sales of radiopharmaceuticals used in diagnostic imaging procedures, such as SPECT for cerebral vascular disorders, dementia, cardiac diseases, and malignant tumors, as well as PET, which is considered useful for early detection of malignant tumors and large vessel vasculitis.
In the therapy field, it provides a radioactive seed for brachytherapy.
By bringing out further emerging potential and usefulness in nuclear medicine and molecular imaging procedures, Nihon Medi-Physics is moving steadily forward to materialize Theranostics (integration of therapeutics and diagnostics) concept in medical care practice, so that it can contribute to solving various issues that medical professional are currently confronting.